Mount Diablo Regional Cancer Center is categorized under Medical Research in Concord, CA and active since 1981.
Mount Diablo Regional Cancer Center was established in 1981, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Medical Research business, which does work in the B2B market, and is classified as a Medical Research, under code number 541720 by the NAICS.
If you are seeking more information, feel free to contact Michael J Messer at the company’s single location by writing to 2571 Park Avenue, Concord, California CA 94520 or by phoning (925) 674-2100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
Business Name: | Mount Diablo Regional Cancer Center |
Contact Person: | Michael J Messer |
Address: | 2571 Park Avenue, Concord, California 94520 |
Phone Number: | (925) 674-2100 |
Website Address: | mdsogroup.com |
Annual Revenue (USD): | $500.000 to $999.999 |
Founded: | 1981 |
Location Type: | Single Location |
Employee Number: | 1 to 4 |
Business Type: | B2B (Business to Business) |
Business Category: | Medical Research |
SIC Code: | 8733 |
NAICS Code: | 541720 |
Share This Business: |
Mount Diablo Regional Cancer Center was started in 1981 to provide professional Medical Research under the SIC code 8733 and NAICS code 541720. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Michael J Messer for inquiries that concern Mount Diablo Regional Cancer Center by calling the company number (925) 674-2100, as your correspondence is most welcome. Additionally, the physical location of the single location of Mount Diablo Regional Cancer Center can be found at the coordinates 37.984167,-122.033913 as well as the street address 2571 Park Avenue in Concord, California 94520.
For its online presence, you may visit Mount Diablo Regional Cancer Center’s website at mdsogroup.com and engage with its social media outlets through on Twitter and on Facebook.